ReviewPharmaceuticals (Basel, Switzerland)2026
Exploiting Metabolic Vulnerabilities in Acute Myeloid Leukemia: Rationale and Evidence for Combining Metabolic Modulators with Conventional Chemotherapy.
Usman Ali Shams et al.PubMed ↗Publisher ↗
No numbers read from the abstract.